Aveanna Healthcare (NASDAQ:AVAH) Major Shareholder Sells $43,680,000.00 in Stock

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) major shareholder Robert Williams, Jr. sold 7,000,000 shares of the business’s stock in a transaction that occurred on Wednesday, June 3rd. The stock was sold at an average price of $6.24, for a total transaction of $43,680,000.00. Following the sale, the insider directly owned 252,899 shares of the company’s stock, valued at approximately $1,578,089.76. This trade represents a 96.51% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Large shareholders that own 10% or more of a company’s stock are required to disclose their transactions with the SEC.

Aveanna Healthcare Stock Performance

Shares of NASDAQ AVAH opened at $6.68 on Monday. Aveanna Healthcare Holdings Inc. has a fifty-two week low of $3.73 and a fifty-two week high of $10.32. The firm has a market capitalization of $1.45 billion, a P/E ratio of 5.66, a P/E/G ratio of 0.75 and a beta of 1.93. The company has a debt-to-equity ratio of 5.35, a current ratio of 1.47 and a quick ratio of 1.47. The company’s 50 day simple moving average is $6.79 and its 200 day simple moving average is $7.71.

Aveanna Healthcare (NASDAQ:AVAH) last issued its earnings results on Thursday, May 14th. The company reported $0.18 EPS for the quarter, beating the consensus estimate of $0.13 by $0.05. The company had revenue of $647.92 million during the quarter, compared to analysts’ expectations of $613.22 million. Aveanna Healthcare had a net margin of 10.37% and a return on equity of 124.68%. The business’s revenue was up 15.9% compared to the same quarter last year. On average, analysts predict that Aveanna Healthcare Holdings Inc. will post 0.6 EPS for the current year.

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on the company. Truist Financial increased their target price on Aveanna Healthcare from $8.00 to $9.00 and gave the company a “hold” rating in a research note on Wednesday, May 20th. Royal Bank Of Canada raised Aveanna Healthcare from a “sector perform” rating to an “outperform” rating and set a $10.00 price target for the company in a research note on Wednesday. Weiss Ratings downgraded shares of Aveanna Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Monday, April 6th. Barclays decreased their price objective on shares of Aveanna Healthcare from $9.50 to $9.00 and set an “overweight” rating for the company in a report on Monday, May 18th. Finally, BMO Capital Markets lowered their target price on shares of Aveanna Healthcare from $11.00 to $10.00 and set an “outperform” rating for the company in a research note on Friday, March 20th. One research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and five have issued a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $10.50.

Institutional Trading of Aveanna Healthcare

Hedge funds and other institutional investors have recently modified their holdings of the company. Caitong International Asset Management Co. Ltd boosted its position in shares of Aveanna Healthcare by 252.4% during the fourth quarter. Caitong International Asset Management Co. Ltd now owns 3,351 shares of the company’s stock worth $27,000 after buying an additional 2,400 shares during the period. Quantbot Technologies LP bought a new stake in Aveanna Healthcare in the 2nd quarter valued at approximately $43,000. Summit Securities Group LLC bought a new stake in Aveanna Healthcare in the 1st quarter valued at approximately $53,000. Oxford Asset Management LLP acquired a new position in Aveanna Healthcare during the 2nd quarter worth approximately $64,000. Finally, Bayesian Capital Management LP bought a new position in shares of Aveanna Healthcare during the 2nd quarter worth approximately $85,000. Institutional investors and hedge funds own 87.96% of the company’s stock.

About Aveanna Healthcare

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.